Research Topics
| Charles R ThomasSummaryAffiliation: Institute for Drug Development Country: USA Publications
| Collaborators
|
Detail Information
Publications
Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trialsCharles R Thomas
Department of Radiation Oncology, The University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
Int J Radiat Oncol Biol Phys 58:1405-10. 2004....- Intraoperative radiation therapy in the multimodality approach to hepatobiliary tract cancerCharles R Thomas
Department of Radiation Oncology, Division of Medical Oncology, Department of Medicine, University of Texas Health Science Center, San Antonio, San Antonio Cancer Institute, San Antonio, TX, USA
Surg Oncol Clin N Am 12:979-92. 2003..Finally, intraoperative reconstruction of severely damaged blood vessels may decrease the clinical manifestation of radiation-induced injury to vessels [68]... - Radiation therapy in the management of thymic tumorsTony Y Eng
Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
Semin Thorac Cardiovasc Surg 17:32-40. 2005..The risk of side effects and late sequelae is generally low when proper radiation technique is employed. This review examines the current role of radiation therapy in the management of these tumors... 
Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysisClifton D Fuller
Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
Cancer 115:5175-83. 2009..The specific aim of this series was to estimate survival for extrahepatic cholangiocarcinoma patients receiving surgery and adjuvant RT using a robust population-based data set...- Image-guided intensity-modulated radiation therapy for gallbladder carcinomaClifton D Fuller
Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, TX, USA
Radiother Oncol 81:65-72. 2006..Early outcome data with this novel radiation planning and delivery technique are encouraging and comparable to previously reported literature... - External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapyMartin Fuss
Department of Radiation Oncology, UTHSC at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229, USA
Gastroenterology 127:S206-17. 2004.... - Quality Research in Radiation Oncology analysis of clinical performance measures in the management of gastric cancerKaryn A Goodman
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Int J Radiat Oncol Biol Phys 85:355-62. 2013..The specific aim was to determine national patterns of radiation therapy (RT) practice in patients treated for stage IB-IV (nonmetastatic) gastric cancer (GC)... - Novel low-kVp beamlet system for choroidal melanomaCarlos Esquivel
Cancer Therapy and Research Center, San Antonio, TX, USA
Radiat Oncol 1:36. 2006..This technique relies on an isocentric rotational approach to deliver dose to target volumes within the eye, while potentially sparing normal structures... 
Effect of body mass index on shifts in ultrasound-based image-guided intensity-modulated radiation therapy for abdominal malignanciesMehee Choi
Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
Radiother Oncol 91:114-9. 2009..The utility of daily image-guidance, particularly for patients with BMI>25.0, is examined...- Multiple management modalities in esophageal cancer: combined modality management approachesMary Koshy
Emory University School of Medicine, Department of Radiation Oncology, Atlanta, Georgia, USA
Oncologist 9:147-59. 2004..There are suggestions of some progress, but this remains a difficult problem area in which management is continuing to evolve... - Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001Mehee Choi
Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
Gynecol Oncol 109:203-9. 2008..The purpose of this study was to estimate CS for ovarian cancer patients through analysis of large-scale cancer registry data... - Current chemotherapy options for thymic epithelial neoplasmsKyriakos P Papadopoulos
Cancer Therapy and Research Center, Institute for Drug Development, San Antonio, TX 78229, USA
Expert Opin Pharmacother 6:1169-77. 2005..This review discusses recent clinical data and the potential role for agents targeting the epidermal growth factor receptor, angiogenesis and apoptotic pathways... - Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414)Michael B Tomblyn
Department of Radiation Oncology, H Lee Moffitt Cancer Center, Tampa, FL, USA
J Thorac Oncol 7:906-12. 2012.... - Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignanciesMartin Fuss
Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Int J Radiat Oncol Biol Phys 59:1245-56. 2004..We assessed the potential for improvement of daily repositioning and the feasibility of daily application... - Radiotherapy for thymoma and thymic carcinomaClifton David Fuller
Department of Radiation Oncology, Graduate Division of Radiological Sciences, The University of Texas Health Science Center at San Antonio, 7979 Wurzbach Road, San Antonio, TX 78229 3900, USA
Hematol Oncol Clin North Am 22:489-507. 2008..Nonetheless, existing literature reports and novel radiotherapy techniques show increasing potential for integration of radiotherapy into the standard therapeutic milieu for carefully selected patient subpopulations... - The efficacy of conventional external beam, three-dimensional conformal, intensity-modulated, particle beam radiation, and brachytherapy for localized prostate cancerTony Y Eng
Department of Radiation Oncology, UTHSCSA Cancer Therapy and Research Center, 7979 Wurzbach Road, San Antonio, TX 78229, USA
Curr Urol Rep 6:194-209. 2005..The addition of hormonal therapy to radiation therapy has been shown to improve the outcome of radiation therapy... - Treatment of early stage thymic tumors: surgery and radiation therapyBenjamin T Gielda
Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, USA
Curr Treat Options Oncol 9:259-68. 2008..The role of radiation therapy in the management of early stage thymic tumors remains controversial and is discussed in detail... - Melatonin as a radioprotective agent: a review- Vijayalaxmi
Department of Radiation Oncology, The University of Texas Health Science Center, San Antonio, 78229, USA
Int J Radiat Oncol Biol Phys 59:639-53. 2004..The potential use of melatonin for protecting individuals from radiation terrorism is also considered... - Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group settingClifton D Fuller
Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
Int J Radiat Oncol Biol Phys 79:481-9. 2011..Variations in target volume delineation represent a significant hurdle in clinical trials involving conformal radiotherapy. We sought to determine the effect of a consensus guideline-based visual atlas on contouring the target volumes... - Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas: Initial clinical resultsClifton David Fuller
Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Radiother Oncol 92:249-54. 2009.... - Method comparison of ultrasound and kilovoltage x-ray fiducial marker imaging for prostate radiotherapy targetingClifton David Fuller
Department of Radiation Oncology, University of Texas Health Science Center-San Antonio, USA
Phys Med Biol 51:4981-93. 2006..Comparison series with multiple image-guidance systems are needed to refine comparisons between targeting methods. However, we do not advocate interchangeability of US and FM localization methods... - A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessmentReshma Jagsi
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA
Int J Radiat Oncol Biol Phys 84:318-22. 2012..The Radiation Oncology Institute commissioned an independent, comprehensive assessment of research needs for the advancement of radiation oncology care... - Image-guided intensity-modulated radiotherapy for pancreatic carcinomaMartin Fuss
Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, Texas, The Cancer Therapy and Research Center, San Antonio, and the Department of Radiation Medicine, Oregon Health and Science University, Portland, OR
Gastrointest Cancer Res 1:2-11. 2007..To present the techniques and preliminary outcomes of ultrasound-based image-guided intensity-modulated radiotherapy (IG-IMRT) for pancreatic cancer... - Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003Paul Okunieff
Department of Radiation Oncology, JP Wilmot Cancer Center, University of Rochester, Rochester, NY 14642, USA
Am J Clin Oncol 26:522-9. 2003..This hypothesis is ready for testing in cancers of the breast, prostate, colon, and in sarcomas. Enlarging the therapeutic window is a major goal that would allow for an increasingly favorable therapeutic gain... - Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up, and surgical approachesMary Koshy
Emory University School of Medicine, Department of Radiation Oncology, Atlanta, Georgia, USA
Oncologist 9:137-46. 2004..For years, the standard of care for esophageal cancer has been surgery; there are several variants of the surgical approach. We will discuss combined modality approaches in part II of this series... - An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactionsColleen A Lawton
Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
Int J Radiat Oncol Biol Phys 69:646-55. 2007..This trial was also designed to test the hypothesis that neoadjuvant hormonal therapy (NHT) followed by concurrent total androgen suppression and RT improves PFS compared with RT followed by adjuvant hormonal therapy (AHT) by > or =10%... - Success breeds success: authorship distribution in the Red Journal, 1975-2011Emma Holliday
Department of Internal Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Int J Radiat Oncol Biol Phys 85:23-8. 2013..The specific aim of this study was to evaluate whether established bibliometric patterns seen in other academic fields were likewise observed in radiation oncology publication parameters... - Multidisciplinary approach to superior sulcus tumorsJuan A Garcia
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Cancer J 11:189-97. 2005 - The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results databaseBrian E Lally
Department of Radiation Oncology, Wake Forest University Health Sciences, Winston Salem, NC 27157 1030, USA
Cancer 110:911-7. 2007..This study was designed to investigate whether the mortality from heart disease, a manifestation of intercurrent disease after postoperative radiotherapy (PORT), has decreased over time for patients with nonsmall cell lung cancer (NSCLC)... - Radiotherapy for thymic neoplasmsClifton D Fuller
Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
J Thorac Oncol 5:S327-35. 2010..However, a review of recent literature shows potential benefits for certain patients based on stage and grade of disease as well as the extent of surgical resection... - Superior sulcus tumors: a mini-reviewVictor C Archie
Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, Texas 78229, USA
Oncologist 9:550-5. 2004..Recent advances in combined-modality therapy have offered the first inkling that a paradigm shift is on the horizon. Here, we review the history and new advances in treating this challenging pulmonary neoplasm... - Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998Clifton D Fuller
Department of Radiation Oncology and Graduate Division of Radiological Sciences, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Cancer 109:1331-43. 2007..Useful prognostic information for cancer survivors is provided by CS analysis. Estimated baseline CS parameters for HNSCC were sought using large-scale cancer registry data... - Definitive chemoradiotherapy for non-small cell lung cancer with N2 diseaseShilpen Patel
Department of Radiation Oncology, Fred Hutchinson Cancer Research Center, University of Washington, 1959 NE Pacific Street, Box 356043, Seattle, WA 98195, USA
Thorac Surg Clin 18:393-401. 2008..With continued diligence to testing new ideas in NSCLC, it is hoped that outcomes will continue to improve the lives of patients with this devastating disease... - ACR appropriateness criteria® resectable rectal cancerWilliam E Jones
UT Health Science Center San Antonio, San Antonio, Texas, USA
Radiat Oncol 7:161. 2012..In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment... - Adhesion molecules in radiotherapyRoxana G Baluna
Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
Radiat Res 166:819-31. 2006..This review is focused on current data concerning the mechanistic interactions of radiation with adhesion molecules and the possible clinical-pathological implications in radiotherapy... - Bibliometric analysis of radiation oncology departmental scholarly publication productivity at domestic residency training institutionsClifton D Fuller
Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
J Am Coll Radiol 6:112-8. 2009..The authors sought to estimate long-term and current departmental research efforts at residency-sponsoring US radiation oncology departments, using modifications of established bibliometric indices... - Positron emission tomography (PET): expanding the horizons of oncology drug developmentLisa A Hammond
Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, Texas 78229, USA
Invest New Drugs 21:309-40. 2003..The progress to date and the challenges of incorporating PET technology into oncology drug development from the preclinical to clinical setting are reviewed in this article... - Gastric cancer: standards for the 21st centuryVictor Archie
Department of Radiation Oncology, The David Geffen U.C.L.A. School of Medicine, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA
Crit Rev Oncol Hematol 57:123-31. 2006..This paper seeks to review the major topics surrounding gastric cancer and cover the results of recently reported and ongoing trials... - Case report and summary of literature: giant perineal keloids treated with post-excisional radiotherapyKristin Jones
Department of Radiation Oncology, University of Texas Health Science Center San Antonio, San Antonio, USA
BMC Dermatol 6:7. 2006..While no single standardized treatment course has been established, several series report excellent outcomes for keloids with post-surgery radiation therapy... - Thymic carcinoma: state of the art reviewTony Y Eng
Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, 78284 7800, USA
Int J Radiat Oncol Biol Phys 59:654-64. 2004..Though our knowledge remains somewhat speculative at present, several scientific, technological and therapeutic innovations may have a potentially significant impact on the future of this disease... - An image worth a thousand lives?Lisa A Hammond
ILEX Products, San Antonio, Texas 78229, USA
Nat Biotechnol 22:677-8. 2004 - Stereotactic body radiation therapy: an ablative treatment option for primary and secondary liver tumorsMartin Fuss
Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Ann Surg Oncol 11:130-8. 2004..We present predominantly peer-reviewed data but also summarize recent clinical developments along with discussions of current ongoing and planned multicenter studies... - Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancerSpencer W Redding
Department of General Dentistry, University of Texas Health Science Center at San Antonio, South Texas Veterans Healthcare System, TX 78229 3900, USA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:47-52. 2004..As with systemic infection, previous fluconazole use appears to be a risk factor for this infection, but not with all patients... - Squamous cell carcinoma of the anal canalDennis L Rousseau
Division of Surgical Oncology, Department of Surgery, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
Surg Oncol 14:121-32. 2005..The surgeon plays a key role in the diagnosis and follow-up of this disease. Surgical salvage with APR for disease persistence or recurrence in carefully selected patients can result in reasonable 5-year survivals... - State of the art: gastrointestinal malignancies in the human immunodeficiency virus (HIV) populationMary Koshy
Department of Radiation Oncology, Department of Radiation Oncology, Emory University School of Medicine, 1365 Clifton Rd NE, Atlanta, GA 30344, USA
Int J Gastrointest Cancer 36:1-14. 2005.... - Current issues in the management of advanced squamous cell carcinoma of the penisSamira Syed
Department of Medicine, Division of Medical Oncology, University Texas Health Science Center, San Antonio, TX, USA
Urol Oncol 21:431-8. 2003..We believe that multi-institutional trials should be designed in order to obtain prospective benchmark data from which to make valid comparisons of outcome... - Melatonin: from basic research to cancer treatment clinics- Vijayalaxmi
Departments of Radiation Oncology, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
J Clin Oncol 20:2575-601. 2002..This study also provides rationale for the design of larger translational research-based clinical trials... - Concomitant weekly cisplatin and thoracic radiotherapy for Pancoast tumors of the lung: pilot experience of the San Antonio Cancer InstituteJonathan B Barnes
Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
Am J Clin Oncol 25:90-2. 2002..These results and those of the recent Southwest Oncology-lead Intergroup prospective phase 2 trial (SWOG-9416/INT-0160) support the use of concomitant chemoradiation followed by an attempt at surgical resection... - Multimodality therapy for Pancoast tumorSamir Narayan
Department of Radiation Oncology, University of California Davis Health System, 4501 X Street, Sacramento, CA 95817, USA
Nat Clin Pract Oncol 3:484-91. 2006..Future potential areas of investigation, including the role of surgery for patients with N2-positive disease and the use of imaging to assess response after induction therapy, are discussed... - Radiation treatment of recurrent pheochromocytoma of the bladder: case report and review of literatureMarco Naguib
Department of Radiation Oncology, University of Texas Health Science Center San Antonio, 7979 Wurzbach Road, San Antonio, TX 78229, U.S.A
Am J Clin Oncol 25:42-4. 2002..In this case report, we describe a patient with a malignant extraadrenal pheochromocytoma, metastatic to the right humerus, and her treatment course of surgery and radiotherapy... - Intraoperative radiation therapy in the multimodality approach to upper aerodigestive tract cancerYvonne M Carter
Section of General Thoracic Surgery, Department of Surgery, University of California-San Francisco School of Medicine, 2330 Post Street, Suite 920, San Francisco, CA 94115, USA
Surg Oncol Clin N Am 12:1043-63. 2003..1). It is hoped that this study will commence in the upcoming year... - Recent clinical trials summaryDaniel R Nathanson
Department of Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
Surg Oncol Clin N Am 13:389-94. 2004..Future phase 3 trials will serve to further perfect this approach and outline the role of HPV and dysplasia in the development and progression of this disease... - Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trialJaffer A Ajani
Department of Gastrointestinal Medical Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Mail Stop 426, Houston, Texas 77030, USA
JAMA 299:1914-21. 2008..Chemoradiation as definitive therapy is the preferred primary therapy for patients with anal canal carcinoma; however, the 5-year disease-free survival rate from concurrent fluorouracil/mitomycin and radiation is only approximately 65%... - Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancerEugene Y Chang
Department of Surgery, Oregon Health and Science University, Mail Code L223A, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA
Am J Surg 193:614-7; discussion 617. 2007..We hypothesized that routine pathologic examination fails to identify some residual cancer... - Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130James A Martenson
North Central Cancer Treatment Group, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
J Clin Oncol 22:3277-83. 2004..Some patients with colon cancer have a high risk of local recurrence postoperatively. This trial was undertaken to determine whether radiation therapy added to an adjuvant chemotherapy regimen improves outcome in high-risk patients... - Management of anal cancer in the HIV-positive populationJohn Kauh
Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
Oncology (Williston Park) 19:1634-8; discussion 1638-40, 1645 passim. 2005..Continued studies and phase III trials will be needed to test new treatment strategies in HIV-infected patients with squamous cell cancer of the anus to determine which treatment protocols provide the greatest benefits... - Multimodality approaches for rectal cancerGary Yang
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA
Curr Probl Cancer 28:316-42. 2004 - Esophageal cancer and the esophagus: challenges and potential strategies for selective cytoprotection of the tumor-bearing organ during cancer treatmentAminah Jatoi
Department of Oncology, Mayo Comprehensive Cancer Center, Mayo Clinic Foundation, Rochester, MN, USA
Semin Radiat Oncol 12:62-7. 2002..An ongoing phase 2 trial by the North Central Cancer Treatment Group (NCCTG) may help clarify a role for cytoprotectants in patients receiving combined-modality therapy for esophageal cancer... - In regard to Jeremic et al., IJROBP 2001;50:19-25Charles R Thomas
Int J Radiat Oncol Biol Phys 52:1145; author reply 1145-6. 2002 - Multimodality approaches for pancreatic cancerGary Y Yang
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
CA Cancer J Clin 55:352-67. 2005..Our aim is to summarize the current state-of-the-art management and future directions regarding the multimodality approach to pancreatic cancer... - Pancoast (superior sulcus) neoplasmsMichael J Kraut
Providence Cancer Center, Southfield, Michigan, USA
Curr Probl Cancer 27:81-104. 2003 - Systemic therapeutic options in thymic malignancies: a glimmer of hopeLisa A Hammond Thelin
Dept of Radiation Medicine, OHSU, M C L337, 3181 SW Sam Jackson Park Road, Portland, USA
Rev Recent Clin Trials 2:191-205. 2007..In addition, potential novel targets such as VEGF, Bcl-2 and c-KIT are assessed... - Radiotherapy for esophageal cancerTodd J Scarbrough
J Clin Gastroenterol 39:349-50. 2005 - A challenge to the therapeutic nihilism of ESPAC-1Mary C Koshy
Int J Radiat Oncol Biol Phys 61:965-6. 2005 - Conditional survival in gastric cancer: a SEER database analysisSamuel J Wang
Department of Radiation Medicine, MC KPV4, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239 3098, USA
Gastric Cancer 10:153-8. 2007..Gastric cancer survival is typically reported in terms of survival from the time of diagnosis. Conditional survival is a more relevant measure of prognosis for patients who have already survived 1 or more years since diagnosis... - Uncommon anal neoplasmsKevin G Billingsley
Division of Surgical Oncology, Department of Surgery, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239, USA
Surg Oncol Clin N Am 13:375-88. 2004..Such an effort may yield modern benchmarks with which to base subsequent patient care algorithms... - Time to move beyond retrospective analyses for thymic neoplasms and conduct a prospective multi-institutional clinical trialCharles R Thomas
Ann Thorac Surg 78:2207; author reply 2207-8. 2004 - Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancerSamuel J Wang
Department of Radiation Medicine, KPV4, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239 3098, USA
J Clin Oncol 26:2112-7. 2008..The purpose of this study was to construct a survival prediction model to enable individualized predictions of the net survival benefit of adjuvant RT for gallbladder cancer patients based on specific tumor and patient characteristics... - Colorectal cancer in Hispanics: a population at risk for earlier onset, advanced disease, and decreased survivalDimitrios Stefanidis
Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA
Am J Clin Oncol 29:123-6. 2006..Modification of screening criteria and treatment paradigms may be required for Hispanics...